icon-folder.gif   Conference Reports for NATAP  
 
  ICAAC 2014 54th Interscience Conference
on Antimicrobial Agents and Chemotherapy
September 5-9, 2014, Washington, DC
Back grey_arrow_rt.gif
 
 
 
Long-Term Efficacy and Safety of E/C/F/TDF (STB) versus EFV/FTC/TDF (ATR) in HIV-1-Infected Treatment Na´ve Black and Non-Black Subjects
 
 
  Reported by Jules Levin
54th Interscience Conference on Antimicrobial
Agents and Chemotherapy
September 5-9, 2014 Washingtion DC, USA
 
WD Hardy1, J Gathe2, K Workowski3, J Stephens4, I Brar5, G Crofoot6, J DeMorin7, K Patel7, H Liu7, K White7, D McColl7, and J Szwarcberg7
1David Geffen School of Medicine, UCLA, Los Angeles, CA; 2Therapeutic Concepts, Houston, TX; 3Emory University, Atlanta, GA; 4Mercer School of Medicine, Atlanta, GA;
5Henry Ford Hospital, Detroit, MI; 6Gordon E. Crofoot, MD, Houston, TX; 7Gilead Sciences Inc., Foster City, CA

ICAAC1.gif

ICAAC2.gif

ICAAC3.gif

ICAAC4.gif

ICAAC5.gif

ICAAC6.gif

ICAAC7.gif

ICAAC8.gif

ICAAC9.gif

ICAAC10.gif

ICAAC11.gif

ICAAC12.gif

ICAAC13.gif

ICAAC14.gif

ICAAC15.gif

ICAAC16.gif

ICAAC17.gif

ICAAC18.gif

ICAAC19.gif